China Health Holding paid $95 million to buy control of Henan Furen Huaiqingtang Pharmaceutical Co. Ltd.

CHHH, which makes natural herbal supplement products based on traditional Chinese medicine, now owns 60 percent of Henan. Henan is a Western-style pharmaceutical company.

CHHH believes that the completion of these acquisitions will enable it to vertically integrate its operations from manufacturing, developing and marketing Chinese herbal based medicinal products, as well as a pharmaceutical drug pipeline, to full distribution and marketing across China, therefore substantially increasing profit margins. Acquisitions should accelerate growth of revenues and earnings, CHHH said.

Source:佚名